MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients

PURPOSE: Determining the optimal strategy to implement systemic treatment modalities has been challenging in triple-negative breast cancer (TNBC). We aim to investigate the role of microRNA-223 (miR-223) as prognostic factor and predictor of response toward chemotherapy in TNBC. PATIENTS AND METHODS...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer (Dove Med Press)
Main Authors: Purwanto, Ibnu, Heriyanto, Didik Setyo, Widodo, Irianiwati, Hakimi, Mohammad, Hardianti, Mardiah Suci, Aryandono, Teguh, Haryana, Sofia Mubarika
Format: Artigo
Jezik:Inglês
Izdano: Dove 2021
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797287/
https://ncbi.nlm.nih.gov/pubmed/33442288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S291014
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki